Antacids Market Share Report 2022-2027

1
Global Antacids Market Research and Forecast
Report 2022-2027




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Antacids Market Research
Report According to the latest report by IMARC
Group, titled Antacids Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2022-2027 the global antacids market
reached a strong growth in 2021.  Antacids are
over-the-counter (OTC) medicines that neutralize
the acid in the stomach to cure heartburn and
indigestion. They cure dyspepsia discomfort,
inflammation, stomach upset, acid indigestion,
and stomach ulcers. They consist of ingredients
such as aluminium, hydroxide, calcium, magnesium,
and bicarbonate. They are self-prescribed
medicines that neutralize acids and inhibit
pepsin. Request Free Sample Report
https//www.imarcgroup.com/antacids-market/request
sample
4
Report Description and Highlights
Report Description

Global Antacids Market Trends One of the
primary factors driving the market is the rising
prevalence of gastroesophageal reflux diseases
(GERD) amongst the masses. Additionally, they are
consumed as chewable tablets in different flavors
that provide the correct dosage amount, improve
patient adherence and are easy to store. Besides
this, the sedentary lifestyles and the numerous
product innovations, such as the introduction of
raft-forming antacids that are strong and safe
medications and offer efficacy and increased
duration of action, are catalyzing the market
growth. Other factors strengthening the market
growth are the easy accessibility of these
antacids through online and offline platforms,
increasing prevalence of heartburn among the
masses and expanding geriatric population that is
susceptible to acidic complications. Looking
forward, the market value is projected to reach a
strong growth during the forecast period
(2022-2027).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Drug Class
Proton Pump Inhibitors H2 Antagonist
Acid Neutralizers Pro-Motility Ag
ents Breakup by Formulation Type Table
t Liquid Powder Othe
rs Breakup by Distribution Channel Hos
pital Pharmacies Retail Pharmacies
Others Breakup by Region

6
Report Description and Highlights
Report Description
North America United S
tates Canada Asia Paci
fic China Japa
n India South
Korea Australia
Indonesia Others Eur
ope Germany Fr
ance United Kingdom
Italy Spain
Russia Others Lati
n America

7
Report Description and Highlights
Report Description
Brazil Mexico
Others Middle East and
Africa Note We are updating our reports, If you
want latest primary and secondary data
(2022-2027) with Cost Module, Business Strategy,
Distribution Channel, etc. Click request free
sample report.

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• AstraZeneca plc Bayer AG Boehringer Ingelheim Inte
  rnational GmbH Dr. Reddys Laboratories Ltd. Glaxo
  SmithKline plc Johnson Johnson Pfizer Inc. Proct
  er Gamble Company Reckitt Benckiser Group PLC Sa
  nofi S.A. Sun Pharmaceutical Industries Ltd. Taked
  a Pharmaceutical Company Limited.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/antacids-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us